E-LIB Suche - Ergebnisse für: Rozzo, G.

1

Effectiveness of Secukinumab in the treatment of moderate–s..:

Ribero, S. ; Ramondetta, A. ; Fabbrocini, G....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 7 - p. , 2021

Link: https://doi.org/10.1111/..

2

Chilblain acral lesions in the COVID‐19 era. Are they marke..:

Ramondetta, A. ; Panzone, M. ; Dapavo, P....
Journal of the European Academy of Dermatology and Venereology. 34 (2020) 9 - p. , 2020

Link: https://doi.org/10.1111/..

3

Observation in vivo de la peau par microscopie à fluorescen..:

La Selva, R. ; Sanlorenzo, M. ; Rozzo, G....
Annales de Dermatologie et de Vénéréologie. 144 (2017) 12 - p. S174 , 2017

Link: https://doi.org/10.1016/..

4

Arrhythmias in a patient with metastatic melanoma treated w..:

Licciardello, M. ; Giura, M.T. ; Rozzo, G....
British Journal of Dermatology. 177 (2017) 2 - p. 584-587 , 2017

Link: https://doi.org/10.1111/..

5

PCR185 Psoriasis-Related Work Productivity Improvement from..:

Bhatia, N. ; Heim, J. ; Schenkel, B...
Value in Health. 26 (2023) 6 - p. S346-S347 , 2023

Link: https://doi.org/10.1016/..

6

CO220 Real-World Effectiveness and Safety in a Phase 4 Stud..:

Bhatia, N. ; Vasquez, J.G. ; Schenkel, B...
Value in Health. 26 (2023) 6 - p. S57 , 2023

Link: https://doi.org/10.1016/..

7

Tildrakizumab efficacy and safety in patients with psoriasi..:

Fernandez, A.P. ; Dauden, E. ; Gerdes, S....
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 10 - p. 1774-1783 , 2022

Link: https://doi.org/10.1111/..

8

Tildrakizumab efficacy, drug survival, and safety are compa..:

Lebwohl, Mark G. ; Leonardi, Craig L. ; Mehta, Nehal N....
Journal of the American Academy of Dermatology. 84 (2021) 2 - p. 398-407 , 2021

Link: https://doi.org/10.1016/..

9

Five‐year efficacy and safety of tildrakizumab in patients ..:

Thaci, D. ; Piaserico, S. ; Warren, R.B....
British Journal of Dermatology. 185 (2021) 2 - p. 323-334 , 2021

Link: https://doi.org/10.1111/..

10

PSS18 Real-World Data Analysis of Dose Escalation and Assoc..:

Bagel, J. ; Glick, B. ; Wu, J.J....
Value in Health. 24 (2021) - p. S223 , 2021

Link: https://doi.org/10.1016/..

11

25985 Efficacy of tildrakizumab 100 mg for PASI improvement..:

Lebwohl, Mark G. ; Langley, Richard G.B. ; Sinclair, Rodney...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB78 , 2021

Link: https://doi.org/10.1016/..

12

15910 Efficacy and safety of long-term tildrakizumab for pl..:

Langley, Richard G. ; Gooderham, Melinda ; Papp, Kim Alexander...
Journal of the American Academy of Dermatology. 83 (2020) 6 - p. AB163 , 2020

Link: https://doi.org/10.1016/..

13

15938 Tildrakizumab efficacy by metabolic syndrome status i..:

Lebwohl, Mark G. ; Gottlieb, Alice B. ; Mendelsohn, Alan M....
Journal of the American Academy of Dermatology. 83 (2020) 6 - p. AB51 , 2020

Link: https://doi.org/10.1016/..

14

Efficacy and Safety of Long-Term Tildrakizumab for Plaque P..:

Langley, Richard G ; Crowley, Jeffrey ; Gooderham, Melinda...
SKIN The Journal of Cutaneous Medicine. 4 (2020) 5 - p. s39 , 2020

Link: https://doi.org/10.25251..

15

15920 Relationship of serum glucose to efficacy and safety ..:

Lebwohl, Mark G. ; Menter, Alan ; Rozzo, Stephen J....
Journal of the American Academy of Dermatology. 83 (2020) 6 - p. AB163 , 2020

Link: https://doi.org/10.1016/..